Typhoid Is Becoming Resistant to Antibiotics, Warn Scientists

Typhoid is notably called an “ancient” disease — it might be as old as human civilization, dating back to 50,000 years ago. Specifically, Salmonella typhi is the bacterium in question that has traveled through the eons with human beings, laying waste to innumerable lives until the discovery of antibiotics in the 20th century. But we could soon be at dire risk from the organism once again — a new study shows the bacterium is developing dangerous levels of antibiotic resistance. That is, oral medication that emerged as a way to treat the disease is becoming increasingly ineffective.

Published in Lancet Microbe, an alarming study found that an antibiotic-resistant strain of Salmonella typhi is spreading internationally. Researchers conducted genome sequencing using 3,489 samples across four high-burden countries: India, Nepal, Pakistan, and Bangladesh. “Specifically, we found that south Asia continues to be an important hub for the generation of antimicrobial resistance,” the authors wrote.



“The speed at which highly-resistant strains of S. Typhi have emerged and spread in recent years is a real cause for concern, and highlights the need to urgently expand prevention measures, particularly in countries at greatest risk,” said infectious disease specialist Jason Andrews from Stanford University.

There are many types of oral antibiotics administered for typhoid, but many strains of the bacterium have been growing resistant to groups of them and have been spreading — predominantly in South Asia — since 2000. This means that the multi-drug resistant strains are immune to a range of antibiotics administered for typhoid, like ampicillin, chloramphenicol, trimethoprim/ sulfamethoxazole, and even new generations of antibiotics like fluoroquinolones and cephalosporins.

While these strains have declined slightly over the years, researchers have now found one strain — XDR Typhi — that is resistant to almost all antibiotic drugs except azithromycin. But the study found that this line of defense could also be weakening: “Concerningly, azithromycin-resistant STyphi have recently been reported in Bangladesh, India, Pakistan, Nepal, and Singapore,” the study reported.

Dr Rohit Bhaskar, Physio
Dr Rohit Bhaskar, Physio Dr. Rohit Bhaskar, Physio is Founder of Bhaskar Health and Physiotherapy and is also a consulting physiotherapist. He completed his Graduation in Physiotherapy from Uttar Pradesh University of Medical Sciences. His clinical interests are in Chest Physiotherapy, stroke rehab, parkinson’s and head injury rehab. Bhaskar Health is dedicated to readers, doctors, physiotherapists, nurses, paramedics, pharmacists and other healthcare professionals. Bhaskar Health audience is the reason I feel so passionate about this project, so thanks for reading and sharing Bhaskar Health.

Post a Comment

Listen to this article

Subscribe

* indicates required